New York City-based Pfizer has been among the largest pharmaceutical companies for many years based on combined prescribed and OTC drug revenue. Today, the company is totally focused on human medicine, divided into four major segments: Primary Care, Specialty Care, Oncology, and Pfizer Centreone....
For divestment, Takeda has been targeting drugs that fall outside of its key focus areas: neuroscience, gastroenterology, oncology, rare diseases and plasma-derived therapies. At the same time, the company has been working to expand the market for established drugs and boost its pipeline. The Ja...
Looking ahead to 2024 and beyond, the pharma industry is set to face further shake-ups in the coming years with many more blockbuster drugs from Bristol Myers Squibb, Novartis and other companies are set to face their first generic or biosimilar competitors in the largest global pharma market,...
In this blog, we will be exploring the growth of the pharmaceutical industry, its future outlook, and the top 10 pharma companies based on their 2022 revenue. The Growth of the Pharmaceutical Industry The pharma market has experienced significant growth during the past two decades, and pharma re...
[1]ADC Market Will Remain Hot in Oncology, Reaching $30B by 2028: Report.Published: Mar 01, 2024.By Tyler Patchen. [2]Evavate-《Antibody Drug Conjugates Report》. [3]2023年报见分晓!默沙东、BMS、诺华、诺和诺德、第一三共,谁猛增谁失速?.智药局...
The substantial investment in cancer treatments is likely to continue, with major pharmaceutical companies like Johnson & Johnson, AstraZeneca, and Merck expected to be the oncology market leaders by 2030. Market Dynamics and Company Performance The success of drugs like Keytruda is reshaping the ...
In the coming years, we expect the rise of technologies that enable decentralized clinical trials to help expand the market share of CROs. Currently the global CRO services market is projected to grow from US$73.38 bn to $163.48 bn by 2029. Here Pharma IQ takes a look at the 10 biggest ...
[1]ADC Market Will Remain Hot in Oncology, Reaching $30B by 2028: Report.Published: Mar 01, 2024.By Tyler Patchen. [2]Evavate-《Antibody Drug Conjugates Report》. [3]2023年报见分晓!默沙东、BMS、诺华、诺和诺德、第一三共,谁猛增谁失速?.智药局.2024-02-05. ...
Pfizer's net income and revenue for thetrailing 12 months (TTM)ending Dec. 31, 2023, were $2.12 billion and $58.5 billion, respectively.45The company'smarket capitalizationwas $145.66 billion as of March 4, 2024. Key Takeaways Pfizer is a pharmaceutical and biotechnology company that developed...
Last year, major pharmaceutical companies heavily invested in R&D, with expenditure ranging from around 14% to 50% of their revenues. Some of the emerging R&D trends include a resurgence in investment and pipeline activity with a focus on radiopharmaceuticals and targeted therapies in oncology. ...